Patents by Inventor Geoffrey A. Head

Geoffrey A. Head has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROTEINACEOUS COMPOUNDS AND USES THEREFOR
    Publication number: 20120178668
    Abstract: The present invention discloses proteinaceous compounds that comprise at least a biologically active portion of a taipan natriuretic peptide (TNP) or a variant or derivative thereof. The invention also relates to the use of these compounds in methods for stimulating vasodilation, natriuresis, diuresis, renin-suppression, bactericidal activity, weight-loss or bone growth in a mammalian host. In specific embodiments, the compounds are useful in the treatment of congestive heart failure.
    Type: Application
    Filed: November 10, 2011
    Publication date: July 12, 2012
    Applicants: BAKER HEART RESEARCH INSTITUTE, THE UNIVERSITY OF QUEENSLAND
    Inventors: Paul Alewood, Geoffrey A. Head, Brian Fry
  • Chimeric proteins with natriuretic activity
    Patent number: 8058242
    Abstract: The present invention discloses proteinaceous compounds that comprise at least a biologically active portion of a taipan natriuretic peptide (TNP) or a variant or derivative thereof. The invention also relates to the use of these compounds in methods for stimulating vasodilation, natriuresis, diuresis, renin-suppression, bactericidal activity, weight-loss or bone growth in a mammalian host. In specific embodiments, the compounds are useful in the treatment of congestive heart failure.
    Type: Grant
    Filed: January 15, 2007
    Date of Patent: November 15, 2011
    Assignees: The University of Queensland, Baker Heart Research Institute
    Inventors: Paul Alewood, Geoffrey A. Head, Bryan Fry
  • PROTEINACEOUS COMPOUNDS AND USES THEREFOR
    Publication number: 20080153747
    Abstract: The present invention discloses proteinaceous compounds that comprise at least a biologically active portion of a taipan natriuretic peptide (TNP) or a variant or derivative thereof. The invention also relates to the use of these compounds in methods for stimulating vasodilation, natriuresis, diuresis, renin-suppression, bactericidal activity, weight-loss or bone growth in a mammalian host. In specific embodiments, the compounds are useful in the treatment of congestive heart failure.
    Type: Application
    Filed: January 15, 2007
    Publication date: June 26, 2008
    Applicants: The University of Queensland, Baker Heart Research Institute
    Inventors: Paul Alewood, Geoffrey A. Head, Bryan Fry